Molecular Basis for Omapatrilat and Sampatrilat Binding to Neprilysin—Implications for Dual Inhibitor Design with Angiotensin-Converting Enzyme
Open Access
- 27 April 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 63 (10), 5488-5500
- https://doi.org/10.1021/acs.jmedchem.0c00441
Abstract
Neprilysin (NEP) and angiotensin-1 converting enzyme (ACE) are two key zinc-dependent metallopeptidases in the natriuretic peptide and kinin systems, and renin-angiotensin-aldosterone system, respectively. They play an important role in blood pressure regulation and reducing the risk of heart failure. Vasopeptidase inhibitors omapatrilat and sampatrilat possess dual activity against these enzymes by blocking the ACE-dependant conversion of angiotensin I to the potent vasoconstrictor angiotensin II while simultaneously halting the NEP-dependant degradation of vasodilator atrial natriuretic peptide. Here we report crystal structures of omapatrilat, sampatrilat and sampatrilat-ASP (a sampatrilat analogue) in complex with NEP at 1.75Å, 2.65Å and 2.6Å, respectively. A detailed analysis of these structures and the corresponding structures of ACE with these inhibitors has provided the molecular basis of dual inhibitor recognition involving the catalytic site in both enzymes. This new information will be very useful in the design of safer and more selective vasopeptidase inhibitors of NEP and ACE for effective treatment in hypertension and heart failure.Keywords
Funding Information
- Research Councils UK (MR/M026647/1)
- National Research Foundation (13082029517)
This publication has 46 references indexed in Scilit:
- How good are my data and what is the resolution?Acta crystallographica. Section D, Structural biology, 2013
- Presenting your structures: theCCP4mgmolecular-graphics softwareActa crystallographica. Section D, Structural biology, 2011
- PHENIX: a comprehensive Python-based system for macromolecular structure solutionActa crystallographica. Section D, Structural biology, 2010
- MolProbity: all-atom structure validation for macromolecular crystallographyActa crystallographica. Section D, Structural biology, 2009
- Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin‐mediated angioedemaBritish Journal of Pharmacology, 2008
- Phasercrystallographic softwareJournal of Applied Crystallography, 2007
- Coot: model-building tools for molecular graphicsActa crystallographica. Section D, Structural biology, 2004
- Clinical analysis of sampatrilat, a combined renal endopeptidase and angiotensin-converting enzyme inhibitor: II: Assay in the plasma and urine of human volunteers by dissociation enhanced lanthanide fluorescence immunoassay (DELFIA)Journal of Pharmaceutical and Biomedical Analysis, 1998
- Refinement of Macromolecular Structures by the Maximum-Likelihood MethodActa crystallographica. Section D, Structural biology, 1997
- The CCP4 suite: programs for protein crystallographyActa crystallographica. Section D, Structural biology, 1994